SCHEMBL14747796

SCHEMBL14747796

Clc1cnn(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.68
PTGS1 P23219 3/20 0.68
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
HTT P42858 2/20 0.56
MITF O75030 1/20 0.56
S1PR4 O95977 1/20 0.56
MAPT P10636 1/20 0.56
THRB P10828 1/20 0.56
XBP1 P17861 1/20 0.56
S1PR1 P21453 1/20 0.56
PAX8 Q06710 1/20 0.56
LMNA P02545 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
GAA P10253 1/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL7137771 0.90 PTGS2 (0.79) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL6157378 0.88 PTGS2 (0.63) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL213767 0.82 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8765028 0.81 HIF1A (0.55) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL7912407 0.78 NPC1 (0.65) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL31276196 0.77 LMNA (0.56) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL14495383 0.77 ALDH1A1 (0.50) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL22795877 0.77 NPC1 (0.49) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL14747808 0.77 PTGS2 (0.68) PTGS2PTGS1NPC1RAB9AALDH1A1
SCHEMBL12854139 0.77 HIF1A (0.69) PTGS2PTGS1NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890822-A INHIBITORS OF CELLULAR METABOLIC PROCESSES 安吉奥斯医药品有限公司 2019-06-14 CN disclosed
US-RE44048-E1 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder G.D. SEARLE LLC (US) 2013-03-05 US disclosed